Association between the ALK Gene Status and the Efficacy of First-line 
Pemetrexed Chemotherapy in Patients with Advanced Lung Adenocarcinoma

Association between the ALK Gene Status and the Efficacy of First-line 
Pemetrexed Chemotherapy in Patients with Advanced Lung Adenocarcinoma

Background and objective Anaplastic lymphoma kinase (ALK) is one of the major driver genes of non-small cell lung cancer (NSCLC). Several studies have shown that the efficacy of pemetrexed in ALK-positive lung cancer is controversial. The aim of this study is to explore the efficacy of pemetrexed-ba...

Full description

Bibliographic Details
Main Authors: Mengge CHEN, Hui CAO, Yingying JI, Yuhuan MAO, Shujing SHEN, Xingya LI
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2017-11-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
ALK
Fracture fusion gene
Pemetrexed
First-line chemotherapy
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2017.11.02

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2017.11.02

Similar Items